TransMedics Group, Inc. (TMDX)

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	488.23	441.54	241.62	93.46	30.26	25.64
Revenue Growth (YoY)	64.43%	82.74%	158.53%	208.83%	18.03%	8.62%
Cost of Revenue	197.88	179.46	87.53	28.19	9.1	9
Gross Profit	290.35	262.08	154.09	65.27	21.16	16.64
Selling, General & Admin	176.08	168.62	117.55	69.9	38.28	24.19
Research & Development	61.75	55.97	36.06	26.81	22.3	18.83
Operating Expenses	237.83	224.59	153.61	96.71	60.59	43.02
Operating Income	52.52	37.5	0.49	-31.44	-39.43	-26.38
Interest Expense	-14.27	-14.41	-10.79	-3.73	-3.87	-3.99
Interest & Investment Income	11.9	13.4	12.5	-	-	-
Currency Exchange Gain (Loss)	1.4	0.7	0.3	-	-1	1
Other Non Operating Income (Expenses)	-1.48	-1.41	0.05	-0.43	0.12	0.65
EBT Excluding Unusual Items	50.06	35.78	2.54	-35.59	-44.18	-28.72
Merger & Restructuring Charges	-	-	-2	-	-	-
Other Unusual Items	-	-	-	-0.58	-	-
Pretax Income	50.06	35.78	-26.67	-36.17	-44.18	-28.72
Income Tax Expense	1.11	0.32	-1.64	0.07	0.04	0.03
Net Income	48.95	35.46	-25.03	-36.23	-44.22	-28.75
Net Income to Common	48.95	35.46	-25.03	-36.23	-44.22	-28.75
Shares Outstanding (Basic)	33	33	33	30	28	25
Shares Outstanding (Diluted)	37	35	33	30	28	25
Shares Change (YoY)	11.90%	8.30%	10.02%	7.02%	11.80%	73.91%
EPS (Basic)	1.46	1.07	-0.77	-1.23	-1.60	-1.16
EPS (Diluted)	1.41	1.01	-0.77	-1.23	-1.60	-1.16
Free Cash Flow	-63.23	-80.94	-164.88	-57.72	-32.38	-30.72
Free Cash Flow Per Share	-1.73	-2.30	-5.07	-1.95	-1.17	-1.24
Gross Margin	59.47%	59.36%	63.77%	69.84%	69.92%	64.88%
Operating Margin	10.76%	8.49%	0.20%	-33.64%	-130.29%	-102.91%
Profit Margin	10.03%	8.03%	-10.36%	-38.77%	-146.11%	-112.13%
Free Cash Flow Margin	-12.95%	-18.33%	-68.24%	-61.76%	-107.01%	-119.82%
EBITDA	74.11	57.25	8.66	-27.96	-37.61	-24.81
EBITDA Margin	15.18%	12.97%	3.58%	-29.92%	-124.28%	-96.75%
D&A For EBITDA	21.59	19.76	8.18	3.48	1.82	1.58
EBIT	52.52	37.5	0.49	-31.44	-39.43	-26.38
EBIT Margin	10.76%	8.49%	0.20%	-33.64%	-130.29%	-102.91%
Effective Tax Rate	2.23%	0.88%	-	-	-	-
Revenue as Reported	488.23	441.54	241.62	93.46	30.26	25.64

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q